Clinical Trial Update: Advanced or Recurrent Solid Tumors Treated With SHetA2 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating SHetA2 in adults with advanced or recurrent solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SHetA2 (SHetA2)

Snippet

Sponsor: University of Oklahoma | Conditions: Solid Tumor, Adult | Phase 1 | Status: RECRUITING